What is the recommended dosage of codeine (opioid) linctus for cough management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Codeine Linctus for Cough

The recommended dose of codeine linctus for cough management is 30-60 mg four times daily (qid), though codeine is actually less preferred among opioid antitussives due to its greater side effect profile compared to alternatives like pholcodine, hydrocodone, or morphine. 1

Specific Dosing Parameters

  • Standard adult dosing: 30-60 mg every 4-6 hours, with a maximum of 240 mg in 24 hours 2
  • FDA-labeled formulation: 10 mL (containing codeine) every 4 hours for adults and children ≥12 years, not exceeding 6 doses in 24 hours 3
  • Guideline-recommended frequency: Four times daily (qid) at 30-60 mg per dose 1

Clinical Context and Positioning

When to Use Codeine

  • Second-line therapy: Codeine should be considered only after demulcents (simple linctus, glycerol-based preparations) have failed 1
  • Short-term use only: Limit to 5-7 days with reassessment if symptoms persist 2
  • Specific indications: Most evidence supports use in cancer-related cough and refractory chronic cough rather than acute respiratory infections 4

Important Limitations

Codeine is explicitly noted as "less preferred" despite being the most researched opioid antitussive because palliative medicine experts consistently report it has a greater side effect profile than other opioid derivatives 1. A well-designed study demonstrated that codeine (30 mg single dose or 120 mg daily) was no more effective than placebo syrup for acute upper respiratory tract infection cough 4.

Preferred Alternatives to Consider First

If opioid therapy is indicated, the CHEST guidelines recommend this hierarchy 1:

  1. Pholcodine (10 mL qid) - where available
  2. Hydrocodone (5 mg bid initially) - where available 5
  3. Dihydrocodeine (10 mg tid)
  4. Morphine (5 mg single-dose trial; if effective, 5-10 mg slow-release bid) 1

Critical Safety Considerations

  • Respiratory depression risk: Particularly at higher doses, with potential for dependence and overdose 2
  • Constipation and drowsiness: Common side effects that may be beneficial if cough disturbs sleep 6
  • Contraindication: Avoid in chronic bronchitis and bronchiectasis as cough suppressants cause sputum retention 2
  • Pediatric caution: Children under 6 years require physician consultation; use is limited due to safety concerns 3, 7

Special Dosing Scenarios

Bedtime dosing strategy: For palliative patients with nonspecific cough, a single bedtime dose of codeine may help suppress cough and induce undisturbed sleep, though this is based on clinical experience rather than evidence 1

Patients already on opioids: If already receiving morphine for other symptoms, increasing the morphine dose by 20% may be more effective than adding codeine 1

Common Pitfall to Avoid

Do not use codeine as first-line therapy for cough. The algorithmic approach should be: demulcents first → then opioid derivatives (preferably pholcodine/hydrocodone/morphine over codeine) → then peripherally-acting antitussives if opioid-resistant → finally nebulized local anesthetics for intractable cases 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cough and Congestion Relief with Guaifenesin and Codeine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Liquid Hydrocodone Medication for Cough

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current drugs for the treatment of dry cough.

The Journal of the Association of Physicians of India, 2013

Research

Codeine: A Relook at the Old Antitussive.

The Journal of the Association of Physicians of India, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.